Thyrotropin Receptor Autoantibody Assessment in Thyroid Eye Disease: Does the Assay Type Matter?

• 영문명: Thyrotropin Receptor Autoantibody Assessment in Thyroid Eye Disease: Does the Assay Type Matter?
• 발행기관: 대한안과학회
• 저자명: Malik Moledina Jonathan Roos Rachna Murthy
• 간행물 정보: 『The Korean Journal of Ophthalmology』Vol.37 No.2, 147~156쪽, 전체 10쪽
• 주제분류: 의약학 > 의학일반
• 파일형태: PDF
• 발행일자: 2023.04.30

영문 초록

Purpose: Thyroid receptor antibodies can quantify thyroid eye disease activity, predict outcomes and aid timing of interventions. The type and generation of assay is frequently unspecified, complicating meta-analyses. To determine the clinical andbiochemical relationships between a second-generation thyrotropin receptor-binding inhibition antibody (TRAb) immunoassay,detecting stimulatory and blocking antibodies, with the thyroid stimulating immunoglobulin (TSI) bridging immunoassaydetecting the stimulatory component only. Methods: Retrospective review of 100 consecutive patients attending a regional specialist service. For each patient and visit,both a TRAb and TSI were performed, and a clinical activity score (CAS) recorded. Results: A significant positive correlation between TRAb and TSI (rho = 0.828, p < 0.01) but a weaker correlation betweenthe assays and CAS (TRAb: rho = 0.439, p < 0.01; TSI: r = 0.357, p < 0.01) were found. In 10% of the episodic data, patientshad a TRAb level that was disproportionately high (39.41 ± 52.84 IU/L), compared to their TSI levels (9.53 ± 12.10 IU/L) with ahigher-than-average CAS (2.47 ± 1.78; range, 0-5). Within 12 months of diagnosis, a significant positive correlation betweenCAS and TRAb (rho = 0.503, p < 0.01) as well as between CAS and TSI (rho = 0.329, p < 0.01) were found. In patients with adiagnosis over 12 months, the correlation with CAS for both TSI and TRAb were Spearman rank correlation coefficient of 0.347(p < 0.01) and 0.327 (p < 0.01), respectively. Conclusions: TRAb and TSI correlate strongly and to a lesser extent with the CAS. For most patients, TRAb can be replacedwith the more economical TSI. TRAb also correlates better with newly diagnosed, more active patients than TSI. In a subsetof patients, blocking antibodies may play a significant pathogenic role, requiring different treatment and monitoring. Furtherstudies are required to investigate this relationship.

목차

Materials and Methods

Results

Discussion

References

키워드

Graves ophthalmopathy Thyroid stimulating immunoglobulins Thyrotropin receptors Thyrotropin-binding inhibitory immunoglobulin